Neogenomics (NEO) Net Cash Flow Growth (1y) (2011 - 2026)
Neogenomics (NEO) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -298.36% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | -7,202.13% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 665.15% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 117.44% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 722.22% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -58.16% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -320.00% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | -1,722.22% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -273.33% |
| 10 | Neogenomics | 1.48 Bn | 1.33 Bn | 80.86 Mn | 35.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.27% |
| Dec 31, 2025 | -190.26% |
| Sep 30, 2025 | 35.69% |
| Jun 30, 2025 | -926.11% |
| Mar 31, 2025 | -96.88% |
| Dec 31, 2024 | -86.15% |
| Sep 30, 2024 | -59.76% |
| Jun 30, 2024 | 72.08% |
| Mar 31, 2024 | -185.08% |
| Dec 31, 2023 | 1,330.45% |
| Sep 30, 2023 | 198.02% |
| Jun 30, 2023 | 160.49% |
| Mar 31, 2023 | 213.70% |
| Dec 31, 2022 | 89.05% |
| Sep 30, 2022 | 39.98% |
| Jun 30, 2022 | 91.10% |
| Mar 31, 2022 | -102.93% |
| Dec 31, 2021 | -84.19% |
| Sep 30, 2021 | 55.85% |
| Jun 30, 2021 | -221.26% |